Table of Contents Table of Contents
Previous Page  215 / 1096 Next Page
Information
Show Menu
Previous Page 215 / 1096 Next Page
Page Background

S202

ESTRO 36

_______________________________________________________________________________________________

Conclusion

We reveal a critical pathway linking ATM and SPOP in

regulation of prostate cancer initiation and therapeutic

responses to radiation. This also provides the first

evidence for a pathophysiological relevant mutation

linked to ATM phosphorylation in the DDR.

Award Lecture: Jack Fowler University of Wisconsin

Award

OC-0375 Dosimetric quantification of the „true“ ano-

inguinal lymphatic drainage of anal cancer patients

H. Dapper

1

, G. Habl

1

, M. Mayinger

1

, M. Oechsner

1

, S.E.

Combs

1

, D. Habermehl

1

1

Klinikum rechts der Isar der Technischen Universität

München, Department of Radiation Oncology, München,

Germany

Purpose or Objective

The ano-inguinal lymphatic drainage (AILD) to the inguinal

lymph nodes is located in the subcutaneous adipose tissue

on the medial thigh. Even though those node-vessels are

very thin and hardly to detect with lymphangiography, this

fact is described and shown in standard anatomy atlases.

New fluorescence-imaging methods like the indocyanine-

green-method corroborate this fact. Anal cancer (AC)

patients undergo a combined chemoradiation (CRT)

protocol and the clinical target volume (CTV) encompasses

the inguinal lymphdrainage because of its affection in

about 30% of all patients. Current contouring atlases

suggest delineation of the primary tumor region, the

mesorectum, inguinal and iliacal lymph nodes but do not

advise the inclusion of the true AILD. Aim of this work was

the retrospective analysis of the incidental dose to the

AILD in an anal cancer patient cohort who underwent

definitive CRT with VMAT-IMRT and using structure sets

according to current guidelines.

Material and Methods

VMAT-IMRT plans of 10 anal cancer patients who had been

treated with CRT during 2014 and 2016 were analyzed. On

these plans we created a new volume, the expected ano-

inguinal lymph drain (AILD). Based on anatomic

descriptions, we connected the soft tissue between the

anus and the inguinal vessels with the following

demarcations: The caudal demarcation was defined 2 cm

below the tuberculum minus. The cranial end of AILD was

at the level of the symphysis (anal) or where no more soft

tissue connection between anus and inguinal could be

identified (inguinal). Ventral demarcation was the femoral

skin, dorsal was the transition of the gluteal muscles to

the subcutaneous adipose tissue. The lateral demarcation

was the adductor muscles (anal) and the medial femur

bone or at least 0.5 cm around femoral vessels (inguinal).

We examined dose parameters (minimum, maximum,

median, V10, V20, V30, V40, V45, V50) that were

delivered to the AILD target volume and the AILD outside

of the previous PTV (AILD-PTV) as represented in the dose-

volume histogram.

Results

All of the 10 patients received at least 39.6 Gy to the

inguinal lymph nodes, 45 Gy to the iliacal lymph nodes and

50.4 Gy to the primary tumor side. The median volume of

AILD and AILD-PTV was 1066 cm3 and 689 cm3,

respectively. Mean Dmin, Dmax and Dmean were 5.5 Gy,

58.1 Gy and 38.4 Gy for AILD and 5.5 Gy, 55.2 Gy and 31.1

Gy for AILD-PTV, respectively. Mean V30, V40, V45, V50

for AILD was 71%, 55%, 45% and 31%, respectively. For

AILD-PTV it was 57%, 29%, 18% and 5%, respectively.

Conclusion

At least 71% of the volume of the expected AILD received

at least an expected required treatment dose of 30 Gy

incidentally. Especially the caudal parts of the created

volumes, with a clear distance to the previous PTVs,

received an inadequate therapeutic dose. Concerning the

low number of locoregional relapses in AC patients after

definitive CRT one has to balance increased skin side

effects by including the AILD into the standard CTV against

a rigid oncological-anatomical interpretation of the local

lymphatic drainage.

Award Lecture: Company Award Lectures

OC-0376 Trajectory Optimization in Radiotherapy

Using Sectioning (TORUS)

C. Locke

1

, K. Bush

1

1

Stanford Cancer Center, Radiation Oncology, Stanford,

USA

Purpose or Objective

One of the most challenging problems in trajectory

optimization for radiotherapy is properly handling the

synchronization of the medical accelerator’s dynamic

delivery. The initial coarse sampling of control points

implemented in a Progressive Resolution Optimization

type approach (VMAT) routinely results in MLC aperture

forming contention issues as the sampling resolution

increases. IMRT based solutions such as 4Pi avoid MLC

synchronization issues through use of a static gantry, but

inevitably suffer from longer treatment times. This work

presents an appoach to optimize continuous, beam-on

radiation trajectories thorough exploration of the

anatomical topology present in the patient and formation

of a novel dual metric graph optimization problem.

Material and Methods

This work presents a novel perspective on trajectory

optimization in radiotherapy using the concept of

sectioning (TORUS). TORUS avoids degradation of 3D dose

optimization quality by mapping the connectedness of

target regions from the BEV perspective throughout the

space of deliverable coordinates. This connectedness

information is then incorporated into a graph optimization

problem to define ideal trajectories. The unique usage of

two distance functions in this graph optimization permits

the TORUS algorithm to generate efficient dynamic

trajectories for delivery while maximing the angular flux

through all PTV voxels. 3D dose optimization is performed

for trajectories using the Varian’s Photon Optimizer

(version 13.6.23).

Results

The TORUS algorithm is applied to three example

treatments: chest-wall, scalp, and the TG-119 C-shape

phantom. When restricted to only coplanar trajectories

for the chest-wall (dose distributions shown in Figure 1)

and scalp cases, the TORUS trajectories are found to

outperform both 7 field IMRT and 2 arc VMAT plans in

delivery time, organ at risk sparing, conformality, and

homogeneity. When the coplanar restriction is removed

for the TG-119 phantom and the static non-coplanar

trajectories are optimized, TORUS trajectories have

superior sparing of the central core avoidance with shorter

delivery times, with similar conformality and